Clinical Trial Update: Evaluation of the Effectiveness of Cannabidiol in Treating Severe Behavioural Problems in Children and Adolescents With Intellectual Disability [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating cannabidiol for severe behavioral problems in children and adolescents with intellectual disability has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Behavioral Disorders in Children
• Intellectual Disability

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: Murdoch Childrens Research Institute | Conditions: Intellectual Disability, Child Behavior Problem | Phase 2 | Status: COMPLETED